Cargando…
High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
Carbapenem-resistant Klebsiella pneumoniae (CRKP) bloodstream infection (BSI) has become increasingly frequent threat recently, especially in the intensive care unit (ICU). High-dose tigecycline (TGC) regimen is proposed due to the limitation of treatment options. We investigated the efficacy and sa...
Autores principales: | Geng, Ting-Ting, Xu, Xin, Huang, Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841956/ https://www.ncbi.nlm.nih.gov/pubmed/29465589 http://dx.doi.org/10.1097/MD.0000000000009961 |
Ejemplares similares
-
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016) -
Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China
por: Li, Lanyu, et al.
Publicado: (2017) -
Allograft hemorrhage as a manifestation of carbapenem-resistant Klebsiella pneumonia infection in kidney transplant recipients: Case series
por: Wang, Zhen, et al.
Publicado: (2020) -
Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis
por: Xia, Guolian, et al.
Publicado: (2020) -
Tigecycline in the treatment of fulminant Mycoplasma pneumoniae pneumonia non-responsive to azithromycin and fluoroquinolone: A case report
por: Yuan, Xin, et al.
Publicado: (2020)